T2 Biosystems, Inc. (TTOO)
USD 0.35
(2.88%)
USD 0.35
(2.88%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -48.19 Million | -50.62 Million | -38.87 Million | -43.21 Million | -45.36 Million | -40.13 Million |
| Net Income | -50.07 Million | -62 Million | -49.24 Million | -46.79 Million | -59 Million | -51.15 Million |
| Depreciation & Amortization | 859 Thousand | 2.27 Million | 2.53 Million | 3.15 Million | 3.64 Million | 2.44 Million |
| Deferred income taxes | -230 Thousand | - | -1.02 Million | -258 Thousand | 280 Thousand | 613 Thousand |
| Stock-based compensation | 4.35 Million | 6.49 Million | 7.09 Million | 3.91 Million | 5.45 Million | 9.89 Million |
| Change in working capital | -4.04 Million | -503 Thousand | -2.17 Million | -6.53 Million | 1.85 Million | -3.94 Million |
| Other non-cash items | 941 Thousand | 3.11 Million | 3.93 Million | 3.31 Million | 2.4 Million | 1.99 Million |
| Investing Cash Flow | -192 Thousand | 9.65 Million | 24.79 Million | -36.26 Million | -761 Thousand | -593 Thousand |
| Investments in PPE | -192 Thousand | -339 Thousand | -460 Thousand | -804 Thousand | -761 Thousand | -593 Thousand |
| Acquisitions | - | - | - | 4000.00 | - | - |
| Investment purchases | - | - | - | -50.71 Million | - | - |
| Sales/Maturities of investments | - | 9.99 Million | 25.25 Million | 15.25 Million | - | - |
| Other Investing Activities | - | 9.99 Million | 25.25 Million | -35.45 Million | - | - |
| Financing Cash Flow | 52.68 Million | 29.05 Million | 20.53 Million | 85.6 Million | 6.35 Million | 49.65 Million |
| Debt repayment | - | - | - | - | -882 Thousand | -1.54 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -330 Thousand | - | - | - | - |
| Common Stock Issuance | 52.75 Million | 29.16 Million | 20.53 Million | 85.31 Million | 6.65 Million | 51.2 Million |
| Other Financing Activities | 52.68 Million | 222 Thousand | 20.53 Million | 296 Thousand | 582 Thousand | 51.2 Million |
| Accounts receivables | 743 Thousand | 2.97 Million | -35 Thousand | -2.27 Million | -1.03 Million | -1.31 Million |
| Accounts payables | 231 Thousand | -1.56 Million | 761 Thousand | -1.65 Million | 2.96 Million | 121 Thousand |
| Inventory | -744 Thousand | -949 Thousand | -1.94 Million | 441 Thousand | -914 Thousand | -1.08 Million |
| Other working capital | -4.27 Million | -959 Thousand | -957 Thousand | -3.05 Million | 851 Thousand | -1.65 Million |
| Cash at beginning of period | 10.32 Million | 23.79 Million | 17.34 Million | 11.21 Million | 50.98 Million | 42.05 Million |
| Cash at end of period | 15.68 Million | 11.88 Million | 23.79 Million | 17.34 Million | 11.21 Million | 50.98 Million |
| Capital Expenditure | -192 Thousand | -339 Thousand | -460 Thousand | -804 Thousand | -761 Thousand | -593 Thousand |
| Effect of forex changes on cash | 1 Million | - | - | - | - | - |
| Net cash flow / Change in cash | 5.36 Million | -11.91 Million | 6.45 Million | 6.13 Million | -39.77 Million | 8.92 Million |
| Free Cash Flow | -48.39 Million | -50.96 Million | -39.33 Million | -44.01 Million | -46.12 Million | -40.73 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -8.96 Million | -13.53 Million | -50.07 Million | -10.34 Million | -15.42 Million | -6.34 Million |
| Depreciation & Amortization | 62 Thousand | 64 Thousand | 859 Thousand | 74 Thousand | 262 Thousand | 267 Thousand |
| Deferred income taxes | - | - | -230 Thousand | -923 Thousand | 3.25 Million | -8.21 Million |
| Stock-based compensation | 208 Thousand | 1.59 Million | 4.35 Million | 728 Thousand | 877 Thousand | 913 Thousand |
| Change in working capital | 93 Thousand | -593 Thousand | -4.04 Million | -523 Thousand | -2.98 Million | 138 Thousand |
| Other non-cash items | 98 Thousand | 2.16 Million | 941 Thousand | 1.56 Million | 623 Thousand | 856 Thousand |
| Investing Cash Flow | - | - | -192 Thousand | -26 Thousand | -13 Thousand | -33 Thousand |
| Investments in PPE | - | - | -192 Thousand | -26 Thousand | -13 Thousand | -33 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 7.27 Million | 2.2 Million | 52.68 Million | 812 Thousand | 21.64 Million | 18.38 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -1000.00 | - | -1.93 Million | 1.93 Million | - |
| Common Stock Issuance | 7.27 Million | 2.2 Million | 52.75 Million | 812 Thousand | 21.7 Million | 18.38 Million |
| Other Financing Activities | 7.27 Million | -1000.00 | 52.68 Million | 812 Thousand | 21.64 Million | 18.38 Million |
| Accounts receivables | 291 Thousand | -168 Thousand | 743 Thousand | -281 Thousand | 210 Thousand | -26 Thousand |
| Accounts payables | -199 Thousand | 358 Thousand | 231 Thousand | 439 Thousand | -1.14 Million | -895 Thousand |
| Inventory | -499 Thousand | 149 Thousand | -744 Thousand | -205 Thousand | -165 Thousand | 575 Thousand |
| Other working capital | 500 Thousand | -932 Thousand | -4.27 Million | -476 Thousand | -1.88 Million | 484 Thousand |
| Cash at beginning of period | 6.2 Million | 15.68 Million | 10.32 Million | 24.31 Million | 16.63 Million | 10.66 Million |
| Cash at end of period | 4.24 Million | 6.2 Million | 15.68 Million | 15.68 Million | 24.87 Million | 16.63 Million |
| Capital Expenditure | - | - | -192 Thousand | -26 Thousand | -13 Thousand | -33 Thousand |
| Effect of forex changes on cash | - | - | 1 Million | 10.74 Million | -6.3 Million | -4.44 Million |
| Net cash flow / Change in cash | -1.96 Million | -9.48 Million | 5.36 Million | -8.63 Million | 8.23 Million | 5.96 Million |
| Free Cash Flow | -9.24 Million | -11.68 Million | -48.39 Million | -9.44 Million | -13.4 Million | -12.42 Million |
5348
INP
MSI
0360
003580
TGLVY